A New Candidate Supporting Drug, Rikkunshito, for the QOL in Advanced Esophageal Cancer Patients with Chemotherapy Using Docetaxel/5-FU/CDDP

Purpose. Docetaxel/5-FU/CDDP (DFP) therapy is a useful treatment for advanced esophageal cancer. However, adverse reactions such as chemotherapy-induced nausea and vomiting (CINV) interfere often with continuation of the chemotherapy. We investigated the efficacy of rikkunshito (TJ-43) on CINV. Meth...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Seike, Junichi, Sawada, Toru, Kawakita, Naoya, Yamamoto, Yota, Yuasa, Yasuhiro, Yamai, Hiromichi, Takachi, Hirokazu, Yoshida, Takahiro, Tangoku, Akira
Format: Artigo
Jezik:Inglês
Izdano: Hindawi Publishing Corporation 2011
Teme:
Clinical Study
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3263686/
https://ncbi.nlm.nih.gov/pubmed/22312520
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2011/715623
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items